Header Logo

Connection

Gary Schaer to Fibrinolytic Agents

This is a "connection" page, showing publications Gary Schaer has written about Fibrinolytic Agents.
Connection Strength

0.114
  1. Determinants of infarct size after thrombolytic treatment in acute myocardial infarction. Am J Cardiol. 1999 Jun 15; 83(12):1600-5.
    View in: PubMed
    Score: 0.041
  2. Beneficial effects of RheothRx injection in patients receiving thrombolytic therapy for acute myocardial infarction. Results of a randomized, double-blind, placebo-controlled trial. Circulation. 1996 Aug 01; 94(3):298-307.
    View in: PubMed
    Score: 0.034
  3. Outcomes of unselected recipients of sirolimus-eluting stents: the Cypher stent U.S. post-marketing surveillance registry. J Invasive Cardiol. 2010 Feb; 22(2):48-55.
    View in: PubMed
    Score: 0.021
  4. Assessment of residual coronary arterial stenosis after thrombolytic therapy during acute myocardial infarction. Am J Cardiol. 1987 Jun 01; 59(15):1231-3.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.